Completed NA NCT07196358
Topical Heparin for Prevention of Hypertrophic Scarring in Split-Thickness Skin Graft Donor Sites
ROLE OF HEPARIN TO PREVENT HYPERTROPHIC SCARNIG IN DONOR AREA OF SPLIT THICKNESS SKIN GRAFT
Sponsor: Dr. Ruth K.M. Pfau Civil Hospital, Karachi
Interventions
Standard dressing Topical Heparin Dressing
Updated 1 time since 2025 Last updated: Sep 21, 2025 Started: Aug 15, 2024 Primary completion: Aug 30, 2025 Completion: Sep 10, 2025
This NA trial investigates Hypertrophic Scarring and Pain, Postoperative and is currently completed. Dr. Ruth K.M. Pfau Civil Hospital, Karachi leads this study, which shows 1 recorded version since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Change History
1 version recorded Completed — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Dr. Ruth K.M. Pfau Civil Hospital, Karachi
Data source: Dr. Ruth K.M. Pfau Civil Hospital, Karachi
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Karachi, Pakistan